FDA Inspection 1210270 — METACEL PHARMACEUTICALS LLC
The FDA completed an inspection of METACEL PHARMACEUTICALS LLC on June 28, 2023 in Watkinsville, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 28, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Watkinsville, GA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)